EUVIMEDEUVIMED entdecken
Crossref

LL37 ‐ DNA Complex Drives Vitiligo Progression Through TLR9 ‐ MyD88 Signaling Pathways

Jingying Wang, Hanxiao Mao, Rulan Liu, Ziyuan Zeng, Lvsha Xie, Yan Yang, Yuanmin He

Pigment Cell & Melanoma Research · 2025

DOI: 10.1111/pcmr.13202 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pigment Cell & Melanoma Research, 2025. Verfasst von Jingying Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Medical Center Hospital of Qionglai City, Qionglai, Sichuan, China. Hauptthemen laut MEDLINE: Vitiligo, Toll-Like Receptor 9, Signal Transduction, Myeloid Differentiation Factor 88. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: the Luzhou Municipal People's Government-Southwest Medical University Science and Technology Strategic Cooperation Project, the Innovation and Entrepreneurship Youth Project of Science and Technology Department of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vitiligo is an autoimmune disorder characterized by chronic depigmentation and milk‐white patches on the skin. Skin infiltration by autoreactive CD8 + T cells causes melanocyte destruction in vitiligo. Multiple risk factors, particularly immune‐related inflammatory factors, are involved in the disappearance of melanocytes. LL37 is a classic damage‐associated molecular pattern molecule that is involved in the development of various autoimmune diseases. An enhanced expression of LL37 in vitiligo is known; however, the exact role of LL37 in melanocyte loss has not yet been elucidated. In the present study, we detected increased LL37 expression in vitiligo serum and lesions. Furthermore, we confirmed that cultured keratinocytes released LL37 after treatment with H 2 O 2 . Moreover, the LL37‐DNA complex enhanced the secretion of CXCL9, CXCL10, and CXCL16 from keratinocytes via the TLR9‐MyD88 signaling pathway and facilitated the migration of CD8 + T cells. Altogether, our study demonstrates that LL37 released from keratinocytes binds to DNA and contributes to melanocyte destruction under oxidative stress‐induced autoimmunity in vitiligo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VitiligoToll-Like Receptor 9Signal TransductionMyeloid Differentiation Factor 88CathelicidinsKeratinocytesDNACD8-Positive T-LymphocytesAntimicrobial Cationic PeptidesHumansMelanocytesMaleDisease ProgressionFemaleAdultHydrogen PeroxideCell Movement

Stichwörter der Autor:innen

LL37autoimmune disordersmelanocytesoxidative stressvitiligo

Substanzen

Toll-Like Receptor 9Myeloid Differentiation Factor 88CathelicidinsTLR9 protein, humanDNAAntimicrobial Cationic PeptidesMYD88 protein, humanHydrogen Peroxide

Autor:innen und Institutionen

  • Department of Dermatology, Medical Center Hospital of Qionglai City, Qionglai, Sichuan, China.
  • Department of Dermatology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.
  • Department of Public Health, Southwest Medical University, Luzhou, Sichuan, China.

Förderung

  • the Luzhou Municipal People's Government-Southwest Medical University Science and Technology Strategic Cooperation Project
  • the Innovation and Entrepreneurship Youth Project of Science and Technology Department of Sichuan Province

Zitieren

APA

Wang, J., Mao, H., Liu, R., Zeng, Z., Xie, L., Yang, Y., & He, Y. (2025). LL37 ‐ DNA Complex Drives Vitiligo Progression Through TLR9 ‐ MyD88 Signaling Pathways. Pigment Cell & Melanoma Research. https://doi.org/10.1111/pcmr.13202

Vancouver

Wang J, Mao H, Liu R, Zeng Z, Xie L, Yang Y, et al. LL37 ‐ DNA Complex Drives Vitiligo Progression Through TLR9 ‐ MyD88 Signaling Pathways. Pigment Cell & Melanoma Research. 2025. doi:10.1111/pcmr.13202

BibTeX
@article{Wang2025,
  author = {Wang, Jingying and Mao, Hanxiao and Liu, Rulan and Zeng, Ziyuan and Xie, Lvsha and Yang, Yan and He, Yuanmin},
  title = {LL37 ‐ DNA Complex Drives Vitiligo Progression Through TLR9 ‐ MyD88 Signaling Pathways},
  journal = {Pigment Cell & Melanoma Research},
  year = {2025},
  doi = {10.1111/pcmr.13202}
}
Kostenlos starten →